Name
PART II | Good Things in Small Packages - Drug and Gene Delivery in the Age of Nanotechnology
Date & Time
Wednesday, October 7, 2020, 3:45 PM - 4:45 PM
Stephen Burgess Qiana L. Matthews
Description

This 2-part session will describe the advancement of drug and gene delivery technologies that can help overcome limitations of getting an active pharmaceutical agent in the body at the right place, at the right dose, at the right time. It will highlight the efforts of local companies and university scientists to increase efficacy of new drugs while limiting potential side effects, all while manipulating delivery systems at the nanoscale.

Part II: Avanti Polar Lipids will showcase their ability to use lipids to manufacture liposomes and nanoparticles that can protect very fragile drugs and DNA sequences from degradation, ensuring the cargo arrives at the site in the body where they need to perform.

A scientist from Alabama State University will share how she harnesses the power of genetic modification of adenovirus, a virus that causes the common cold, to create vaccines for infectious diseases such as HIV or Zika virus.

You are invited to a Zoom webinar.

When: Oct 7, 2020 03:30 PM Central Time (US and Canada)

Topic: PART II | Good Things in  Small Packages - Drug and Gene Delivery  in the Age of Nanotechnology

 

Please click the link below to join the webinar:

https://us02web.zoom.us/j/88204867935

Or iPhone one-tap :

    US: +13017158592,,88204867935#  or +13126266799,,88204867935#

Or Telephone:

    Dial(for higher quality, dial a number based on your current location):

        US: +1 301 715 8592  or +1 312 626 6799  or +1 929 205 6099  or +1 253 215 8782  or +1 346 248 7799  or +1 669 900 6833

Webinar ID: 882 0486 7935

    International numbers available: https://us02web.zoom.us/u/kxIvA9QKh

Virtual Session Link
Session Description

This 2-part session will describe the advancement of drug and gene delivery technologies that can help overcome limitations of getting an active pharmaceutical agent in the body at the right place, at the right dose, at the right time. It will highlight the efforts of local companies and university scientists to increase efficacy of new drugs while limiting potential side effects, all while manipulating delivery systems at the nanoscale.

Part II: Avanti Polar Lipids will showcase their ability to use lipids to manufacture liposomes and nanoparticles that can protect very fragile drugs and DNA sequences from degradation, ensuring the cargo arrives at the site in the body where they need to perform.

A scientist from Alabama State University will share how she harnesses the power of genetic modification of adenovirus, a virus that causes the common cold, to create vaccines for infectious diseases such as HIV or Zika virus.